OTC Markets OTCPK - Delayed Quote USD
Aibotics Inc. (AIBT)
0.0130
-0.0010
(-7.14%)
At close: April 22 at 3:44:07 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Benjamin Kaplan | Chairman, Chief Executive and Financial Officer & President | 288k | -- | 1972 |
| Dr. Saphire Longmore MBBS | Chief Medical Officer Of Caribbean Affairs | -- | -- | -- |
Aibotics Inc.
100 SE 2nd Street
Suite 2000
Miami, FL 33131
United States
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Aibotics Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Florida. Aibotics Inc. is a subsidiary of EHAVE, Inc.
Corporate Governance
Aibotics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Related Tickers
MRPI Mera Pharmaceuticals, Inc.
0.0001
0.00%
DNAG DNAPrint Genomics, Inc.
0.0000
0.00%
MYMX Mymetics Corporation
0.0003
0.00%
SPPH Spencer Pharmaceutical Inc.
0.0001
0.00%
HAVLF HAVN Life Sciences Inc.
0.0010
0.00%
RSPI RespireRx Pharmaceuticals Inc.
0.0017
0.00%
TXTM ProText Mobility, Inc.
0.0008
0.00%
BIXT Bioxytran, Inc.
0.1594
-3.39%
ERNA Ernexa Therapeutics Inc.
0.1842
+3.54%
GLYC GlycoMimetics, Inc.
0.2265
+3.38%